Assessing the Role of Reversible Contraceptives in the Health Care of Women as it Pertains to Cancer Prevention.

Adv Ther

The Division of Clinical Genetics, Department of Obstetrics and Gynecology, Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.

Published: November 2017

AI Article Synopsis

  • Effective birth control methods do more than just prevent pregnancy; they can also lower the risk of certain cancers in women.
  • Hormonal and non-hormonal birth control can affect the chances of getting cancers like breast, colon, and female genital cancers.
  • People sometimes worry about the safety of these birth control methods, but using them can actually help reduce the risk of some serious health issues for women.

Article Abstract

The use of effective and reversible contraception is characterized by many non-contraceptive benefits distinct from its ability to prevent pregnancy. Notably, the use of hormonal and non-hormonal birth control methods is known to impact the risk for developing certain female genital cancers as well as breast and colon cancers. We present here the current understanding of the role of effective and reversible contraceptives in the prevention and development of female genital cancers along with breast and colon cancers. Despite ongoing but unsubstantiated concerns regarding the use of hormonal and intrauterine contraceptives for a variety of clinical outcomes including cancer, contraceptive use in high- and low-risk reproductive-aged women remains an important part of cancer risk reduction for many malignancies.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-017-0623-7DOI Listing

Publication Analysis

Top Keywords

reversible contraceptives
8
effective reversible
8
female genital
8
genital cancers
8
breast colon
8
colon cancers
8
assessing role
4
role reversible
4
contraceptives health
4
health care
4

Similar Publications

Objective: Female sterilization is a common form of contraception in the United States. On June 24, 2022, the United States Supreme Court eliminated the federal standard protecting a woman's right to abortion via Dobbs v. Jackson Women's Health Organization.

View Article and Find Full Text PDF

Objectives: Long-acting reversible contraception (LARC) provides continuous pregnancy prevention to women for a period of 3 to 12 years, and it is very safe and effective. The aim of this study was to determine the prevalence, determinants and willingness to use LARC among undergraduate female students attending public and private universities in Ekiti State, Southwest Nigeria DESIGN: This survey employed a cross-sectional comparative study design.

Setting: Public and private universities in Ekiti State, Southwest Nigeria.

View Article and Find Full Text PDF

Background: The postpartum period remains a very important period during which contraceptive needs can be met and a significant reduction of maternal and foetal morbi-mortality achieved. This study aimed to evaluate past contraceptive experience and identify factors associated with the desire for postpartum family planning among women in late pregnancy.

Methods: We conducted a cross-sectional survey from September 2020 to December 2021 in four major health facilities of the Nkongsamba Health District, Cameroon, and consecutively included all pregnant women in late pregnancy, who came for antenatal follow-up in these health facilities.

View Article and Find Full Text PDF

Background: The development of long-acting products of a characterized drug substance is of great interest. It is possible to support the development of these products with available clinical data by matching the exposure to a predefined bracket of a minimal concentration for efficacy and a maximal concentration for safety. This bracketing approach would cut down on the time and cost of new long-acting contraceptive products progressing to market.

View Article and Find Full Text PDF

Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis.

Addict Sci Clin Pract

January 2025

Departments of Family and Community Medicine and Health and Clinical Outcomes Research, Saint Louis University School of Medicine, Saint Louis, MO, USA.

Background: The postpartum period provides an opportunity for birthing people with opioid use disorder (OUD) to consider their future reproductive health goals. However, the relationship between the use of medication for opioid use disorder (MOUD) and contraception utilization is not well understood. We used multistate administrative claims data to compare contraception utilization rates among postpartum people with OUD initiating buprenorphine (BUP) versus no medication (psychosocial services receipt without MOUD (PSY)) in the United States (US).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!